MacroGenics grants director 44,000 stock options

The option and restricted stock unit awards have separate vesting schedules, with option vesting beginning one month after grant.

Available on EDGAR 11/03/2026 - 04:34 PM EST Accepted by SEC EDGAR 11/03/2026 - 04:33 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

MacroGenics (MGNX) director Michael Vasconcelles received awards of 44,000 stock options and 7,500 restricted stock units on October 30, 2026. The options have a $2.40 exercise price and vest in monthly, cumulative 1/36th increments, rounded up to whole shares, beginning one month after grant; they expire October 30, 2036. Each restricted stock unit represents a contingent right to one common share and vests 33% one year after grant and 33% each year thereafter.

Insider Trade Summary

Grant/Award: 51,500 shares

Grant/Award 2 txns

Insider VASCONCELLES MICHAEL

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy) F1	44,000	$0.00	$0.00
Grant/Award	Restricted Stock Unit F2	7,500	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 44,000 contracts (Direct); Restricted Stock Unit — 7,500 contracts (Direct)

Footnotes (2)

1. F1. The option will vest and become exercisable in monthly, cumulative 1/36th increments (rounded upwards for whole shares) beginning one month from the date of grant.
2. F2. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Key Figures

Stock options awarded: 44,000 stock options Option exercise price: $2.40 per share Option vesting schedule: Monthly, cumulative 1/36th increments +4 more

7 metrics

Stock options awarded 44,000 stock options Awarded October 30, 2026

Option exercise price $2.40 per share Options awarded October 30, 2026

Option vesting schedule Monthly, cumulative 1/36th increments Begins one month after grant; increments are rounded upwards for whole shares

Option expiration October 30, 2036 Options awarded October 30, 2026

Restricted stock units awarded 7,500 restricted stock units Awarded October 30, 2026

Shares per restricted stock unit 1 common share Each restricted stock unit represents a contingent right to receive one share

Restricted stock unit vesting 33% of total shares One year after grant and 33% each year thereafter

Key Terms

Stock Option (right to buy), Restricted Stock Unit, contingent right, monthly, cumulative 1/36th increments

4 terms

Stock Option (right to buy) technical

"44,000 Stock Option (right to buy)"

Restricted Stock Unit technical

"Each restricted stock unit (RSU) represents"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

contingent right technical

"a contingent right to receive one share"

monthly, cumulative 1/36th increments technical

"monthly, cumulative 1/36th increments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many securities were included in Michael Vasconcelles' MGNX award?

On October 30, 2026, director Michael Vasconcelles was awarded 44,000 stock options and 7,500 restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VASCONCELLES MICHAEL

(Last) (First) (Middle)

9704 MEDICAL CENTER DRIVE

(Street)

ROCKVILLE MARYLAND 20850

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MACROGENICS INC [ MGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$2.4	10/30/2026		A		44,000		(1)	10/30/2036	Common Stock	44,000	$0	44,000	D
Restricted Stock Unit	(2)	10/30/2026		A		7,500		(2)	(2)	Common Stock	7,500	$0	7,500	D

Explanation of Responses:

1. The option will vest and become exercisable in monthly, cumulative 1/36th increments (rounded upwards for whole shares) beginning one month from the date of grant.

2. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Remarks:

	/s/ Beth A. Smith, Attorney-in-fact	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)